Elijah R. Behr
YOU?
Author Swipe
View article: Brugada Syndrome: an exemplar for the genomic basis of sudden death
Brugada Syndrome: an exemplar for the genomic basis of sudden death Open
The inherited arrhythmia syndrome, Brugada Syndrome (BrS), is a leading cause of autopsy negative sudden death: the sudden arrhythmic death syndrome. Historically, BrS was believed to exhibit a Mendelian (autosomal dominant) mode of inheri…
View article: The Clinical Significance of Atrial Fibrillation in Non–High-Risk Brugada Syndrome
The Clinical Significance of Atrial Fibrillation in Non–High-Risk Brugada Syndrome Open
The presence of AF in non-high-risk BrS does not identify patients with higher risk of VAs. However, early-onset AF (<20 years) defines a distinct subgroup with elevated risk. Patients with AF and BrS have a significantly higher risk of SS…
View article: 1-036 RIDGE<sup>TM</sup>-1: a phase 1b interventional study to evaluate safety and efficacy of TN-401, an adeno-associated virus serotype 9 (AAV9) investigational gene therapy, in adults with <i>PKP2</i>-associated arrhythmogenic right ventricular cardiomyopathy (ARVC)
1-036 RIDGE<sup>TM</sup>-1: a phase 1b interventional study to evaluate safety and efficacy of TN-401, an adeno-associated virus serotype 9 (AAV9) investigational gene therapy, in adults with <i>PKP2</i>-associated arrhythmogenic right ventricular cardiomyopathy (ARVC) Open
View article: 1-030 Mainstream genetic testing in an ICC specialist centre: experience under national testing criteria
1-030 Mainstream genetic testing in an ICC specialist centre: experience under national testing criteria Open
View article: Novel start codon variant in the 5’UTR of LDLR associated with familial hypercholesterolaemia
Novel start codon variant in the 5’UTR of LDLR associated with familial hypercholesterolaemia Open
Familial hypercholesterolaemia (FH) is a genetic disorder due to pathogenic variants in LDLR , APOB , and PCSK9 genes, characterised by elevated low-density lipoprotein cholesterol (LDL-C) concentration and a significantly increased risk o…
View article: Clinical care of family members of patients with dilated cardiomyopathy
Clinical care of family members of patients with dilated cardiomyopathy Open
Genetic family screening following the detection of a pathogenic or likely pathogenic variant in a proband with dilated cardiomyopathy (DCM) remains one of the main applications of genetic testing. While cardiac screening is recommended fo…
View article: Accumulating evidence for epicardial ablation in malignant forms of Brugada syndrome: summary of two randomized clinical trials
Accumulating evidence for epicardial ablation in malignant forms of Brugada syndrome: summary of two randomized clinical trials Open
View article: High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: A multicenter cohort study and review of the literature
High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: A multicenter cohort study and review of the literature Open
This multicenter study highlights the severe phenotype associated with LP/P RBM20 variants, with a high incidence of VA, particularly in males. Additionally, this study presents 11 truncating variants mainly observed in older individuals.
View article: Exercise and phenotypic progression in arrhythmogenic cardiomyopathy
Exercise and phenotypic progression in arrhythmogenic cardiomyopathy Open
Background Intense exercise may exacerbate disease expression in arrhythmogenic cardiomyopathy (ACM). Natural history and phenotypic progression of ACM is still poorly understood. Purpose The aim of the study was to investigate the impact …
View article: aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study
aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study Open
Background Little is known about the distribution and clinical course of patients with inherited arrhythmia syndrome (IAS) and concomitant atrial arrhythmias (AAs). Aim 1) To characterize the distribution of AAs in patients with IAS and 2)…
View article: Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial
Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial Open
BACKGROUND: The PRAETORIAN trial (A Prospective, Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) investigated the efficacy and safety of the subcutaneous implantable cardioverter defibr…
View article: Synthetic electrocardiograms for Brugada syndrome: from data generation to expert cardiologists evaluation
Synthetic electrocardiograms for Brugada syndrome: from data generation to expert cardiologists evaluation Open
Aims Synthetic electrocardiograms (ECGs) for inherited cardiac diseases may overcome the issue related to data scarcity for artificial intelligence (AI)-based algorithms. This study aimed to evaluate experienced cardiologists’ ability to d…
View article: The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)
The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS) Open
The pharmacological provocation test is a pivotal tool in cardiac electrophysiology for the diagnosis of potential causes of sudden cardiac death, sudden cardiac arrest (SCA), arrhythmias, symptoms, or ECG abnormalities. The 2022 European …
View article: High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial
High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial Open
Background and Aims The feasibility and impact of high intensity exercise programmes in patients with hypertrophic cardiomyopathy (HCM) are unknown. This study was conducted to determine the feasibility of a high intensity exercise program…
View article: Rare disease gene association discovery in the 100,000 GenomesProject
Rare disease gene association discovery in the 100,000 GenomesProject Open
Up to 80% of rare disease patients remain undiagnosed after genomic sequencing 1 , with many probably involving pathogenic variants in yet to be discovered disease–gene associations. To search for such associations, we developed a rare var…
View article: Influence of age and sex on the diagnostic yield of inherited cardiac conditions in sudden arrhythmic death syndrome decedents
Influence of age and sex on the diagnostic yield of inherited cardiac conditions in sudden arrhythmic death syndrome decedents Open
Aims Sudden arrhythmic death syndrome (SADS) refers to a sudden death, which remains unexplained despite comprehensive post-mortem examination and a toxicological screen. We aimed to investigate the impact of age and sex on the overall dia…
View article: Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial Open
BACKGROUND: Inappropriate therapy (IAT) is an undesirable side effect of implantable cardiac defibrillator (ICD) therapy. Early studies with the subcutaneous ICD (S-ICD) showed relatively high inappropriate shock (IAS) rates. The PRAETORIA…
View article: Corrigendum to “Analysis of buccal mucosa as a prognostic tool in children with arrhythmogenic cardiomyopathy” [Progress in Pediatric Cardiology 64 (2022) 101458]
Corrigendum to “Analysis of buccal mucosa as a prognostic tool in children with arrhythmogenic cardiomyopathy” [Progress in Pediatric Cardiology 64 (2022) 101458] Open
View article: The Impact of Coronary Ischemia Assessment on Outcomes in Those With Scar‐Dependent Ventricular Tachycardia
The Impact of Coronary Ischemia Assessment on Outcomes in Those With Scar‐Dependent Ventricular Tachycardia Open
Background Guidance and outcomes of coronary ischemia assessment (IA) in those with structural heart disease (SHD), presenting with monomorphic ventricular tachycardia (MMVT) is unclear. Objectives To assess the impact of IA on arrhythmic …
View article: aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study
aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study Open
Aims Little is known about the distribution and clinical course of patients with inherited arrhythmia syndrome (IAS) and concomitant atrial arrhythmias (AAs). The aim of the study is (i) to characterize the distribution of AAs in patients …
View article: Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial Open
BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to overcome the risk of lead-related complications associated with the transvenous implantable cardioverter-defibrillator (TV-ICD). In contrast to th…
View article: Novel real-time automation of combined frequency and low voltage substrate mapping to guide ablation for Brugada syndrome: a case report
Novel real-time automation of combined frequency and low voltage substrate mapping to guide ablation for Brugada syndrome: a case report Open
Background Brugada syndrome (BrS) is an inherited cardiac condition that increases the risk of sudden cardiac death (SCD) due to ventricular arrhythmias. Catheter ablation has been shown to effectively reduce recurrent ventricular fibrilla…
View article: A Rare Noncoding Enhancer Variant in <i>SCN5A</i> Contributes to the High Prevalence of Brugada Syndrome in Thailand
A Rare Noncoding Enhancer Variant in <i>SCN5A</i> Contributes to the High Prevalence of Brugada Syndrome in Thailand Open
BACKGROUND: Brugada syndrome (BrS) is a cardiac arrhythmia disorder that causes sudden death in young adults. Rare genetic variants in the SCN5A gene encoding the Na v 1.5 sodium channel and common noncoding variants at this locus are robu…
View article: Genetic testing for inherited arrhythmia syndromes and cardiomyopathies: results of the European Heart Rhythm Association survey
Genetic testing for inherited arrhythmia syndromes and cardiomyopathies: results of the European Heart Rhythm Association survey Open
Aims Indications and clinical impact of genetic testing for cardiac diseases have increased significantly over the past years. The aim of this physician-based European Heart Rhythm Association (EHRA) survey was to assess current clinical p…
View article: Left ventricular morphology and geometry in élite athletes characterised by extreme anthropometry
Left ventricular morphology and geometry in élite athletes characterised by extreme anthropometry Open
Athletes with high BMI have similar LV dimensions but greater wall thickness and higher prevalence of concentric remodelling compared to very tall athletes. Athletes with high BMI and large BSA have the widest LV dimensions.
View article: Brugada syndrome: can polygenic risk scores help the clinician?
Brugada syndrome: can polygenic risk scores help the clinician? Open
Graphical AbstractRare and polygenic risk and potential impact on disease manifestation in Brugada syndrome: P/LP, pathogenic or likely pathogenic; VT, ventricular tachycardia; VF, ventricular fibrillation; RVOT, right ventricular outflow …
View article: 2 Insights into the aetiology and temporal trends in cardiac mortality in the young: a 21-year review of national and registry data in england and wales
2 Insights into the aetiology and temporal trends in cardiac mortality in the young: a 21-year review of national and registry data in england and wales Open
Background An accurate representation of the incidence and aetiology of cardiac and sudden cardiac death (SCD) is vital for healthcare policymakers to effectively allocate resources for preventative strategies. Aim We aimed to report on th…
View article: Type 1 Brugada Pattern May Be Provoked by Ajmaline in Some Healthy Subjects: Results From a Clinical Trial
Type 1 Brugada Pattern May Be Provoked by Ajmaline in Some Healthy Subjects: Results From a Clinical Trial Open
View article: Autopsy of all young sudden death cases is important to increase survival in family members left behind
Autopsy of all young sudden death cases is important to increase survival in family members left behind Open
Sudden cardiac death (SCD) is an important public health problem worldwide, accounting for an estimated 6–20% of total mortality. A significant proportion of SCD is caused by inherited heart disease, especially among the young. An autopsy …
View article: Evolution of the ECG in idiopathic ventricular fibrillation survivors: results from a single-centre UK registry
Evolution of the ECG in idiopathic ventricular fibrillation survivors: results from a single-centre UK registry Open
Background Idiopathic ventricular fibrillation (VF) is a diagnosis of exclusion in subjects with an unexplained cardiac arrest and no evidence of overt structural or electrical cardiac abnormalities (1). It can be associated with an early …